Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREDCOVID: Early Prednisone in Mild COVID-19 Pneumonia
NCT04451174Phase 3Terminated
- Sponsor
- Universidad de Chile
- Start
- Jun 2020
- Primary completion
- Jan 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of prednisone in coronavirus disease 2019 (COVID-19), sponsored by Universidad de Chile. Started Jun 2020; status: terminated.
02
Drugs
prednisone
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04451174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04451174.